Flow Neuroscience
Sweden - MalmöBiotechnology
Focus: Flow Neuroscience develops at-home, non-invasive transcranial direct current stimulation (tDCS) headsets targeting neurological indications, particularly major depressive disorder. The company is a pre-revenue biotech operating from Malmö, Sweden with a hardware-centric neurotech model.
Profile data last refreshed 35m ago · AI intelligence enriched 2mo ago
Open Jobs
1
Should You Work at Flow Neuroscience?
AI assessmentAttractive for early-stage innovators seeking neurotech exposure and equity upside, but high risk due to pre-revenue status, minimal hiring activity (0 active roles), and unproven clinical efficacy.
Why Work Here
- First-mover advantage in at-home brain stimulation—a differentiated, non-invasive modality with significant unmet need in depression and neurology.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Transcranial direct current stimulation
Major Depressive DisorderClinical Trials (1)
NCT05202119Empower: tDCS for Major Depressive Disorder at Home
N/AHelp build intelligence for Flow Neuroscience
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.